{"name":"Laekna Limited","slug":"laekna-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"LAE102 intravenous administration","genericName":"LAE102 intravenous administration","slug":"lae102-intravenous-administration","indication":"Other","status":"phase_1"},{"name":"[14C]Afuresertib","genericName":"[14C]Afuresertib","slug":"14c-afuresertib","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"LAE102 intravenous administration","genericName":"LAE102 intravenous administration","slug":"lae102-intravenous-administration","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"[14C]Afuresertib","genericName":"[14C]Afuresertib","slug":"14c-afuresertib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1XTlNBVnppaUtRdDNTZ1oyOFBrT0Z3Xy1zeF9fQW5vbWRyVzhqTnpOSjJIX3hDaFZFeVNodlVTdDM1ZFhmbHAxcThvTl9penJXRUJjTkpn?oc=5","date":"2023-07-04","type":"pipeline","source":"Yahoo Finance UK","summary":"Laekna, Inc. (2105.HK) stock price, news, quote and history - Yahoo Finance UK","headline":"Laekna, Inc. (2105.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxObFl1Yzk4WXdWYmhSLWdlMHFJcE42aG02eGFPbDJmU3lLMGhQNnFBbWNRb0lSQTBTeTNtQTE3MGhBZXZ4MFZiYWFBeXdHQVVQVHM5bzJZeXBsSDVaX25vYmlkdlVmTDkwdkNxRHl0TTQ4VnVnbGtYOWhwRll3ekItME5pRlBTaTYwVEpQaEN6MXhkTGhpa3NoLUdRMXdjaFRSVVBBNkdRTmVZTUQxY3dmNkNydERBY3VaZlduVFA5aDRaT3FEbG9aVlN6SVRoVV9PZXFwbHhvekxNT3k5aEhTVg?oc=5","date":"2023-06-29","type":"pipeline","source":"PharmiWeb.com","summary":"Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange - PharmiWeb.com","headline":"Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}